Market Sentiment for GILD

Live Market Sentiment

Strong Negative (-0.8858)

(Latest daily score)

Predicted Return

-2.47%

7-day sentiment average

Advisory Opinion

Hold

Derived from sentiment trend

News Items (period)

1,923

The table below gives each of the most recent headlines of the stock and the negative, neutral, positive aggregated sentiment score.

Date	Headline	Source	Sentiment
2026-04-04	Galapagos NV (GLPG) Signs Agreement with Gilead on Ouro Medicines Assets	Insider Monkey	Strong Positive (0.9261)
2026-04-02	Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know	Zacks	Neutral (0.0037)
2026-04-02	A Look At Gilead Sciences (GILD) Valuation After Recent Mixed Share Price Performance	Simply Wall St.	Strong Negative (-0.4173)
2026-04-01	Gilead Extends Tender Offer to Acquire Arcellx	Business Wire	Strong Positive (0.4104)
2026-04-01	Gilead Sciences's Q1 2026 Earnings: What to Expect	Barchart	Neutral (-0.0105)
2026-04-01	LLY to Buy Neuroscience Biotech Centessa Pharmaceuticals in $7.8B Deal	Zacks	Neutral (0.0798)
2026-04-01	5 Biotechs That Big Pharma Could Snap Up as Oncology M&A Heats Up	24/7 Wall St.	Positive (0.1502)
2026-03-31	Gilead Sciences (GILD) Rises Yet Lags Behind Market: Some Facts Worth Knowing	Zacks	Positive (0.1955)
2026-03-31	Gilead Sciences Shows Solid Early Yeztugo Persistence but Limited Market Expansion, RBC Says	MT Newswires	Positive (0.3989)
2026-03-31	Galapagos Partners With Gilead on Gamgertamig, Unlocks $500M Cash and Eyes 2027 Registrational Trials	MarketBeat	Strong Positive (0.7860)